SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED

Summary

SHPL is a 50:50 joint venture established in 2001 between HUTCHMED and Shanghai Pharma. It primarily manufactures, sells and distributes own-brand cardiovascular diseases medicines in China.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 485 M

Avg. Deal Size£ 485 M

Market Context